Abstract |
The present study elucidated that N-CWS augments the cytolytic activity against 3LL tumor cells of LAK cells from N-CWS-immunized mice administered i.p. with rIL-2. This augmentative effect of N-CWS was not seen when the LAK cells were prepared from normal mice. The cytolytic activity was predominantly expressed in the NAPC prepared from the site of injection of rIL-2, and repeated administrations of rIL-2 were required to induce and maintain this potent cytolytic activity in vivo. Serological analysis revealed that the LAK cells were positive for Thy 1.2 and asialo GM1 antigens and that they were not classical CTL or NK cells. The administration of rIL-2 statistically prolonged the MST of mice bearing LAK-sensitive 3LL cells but not the MST of mice bearing LAK-resistant EL-4 leukemia. Furthermore, combination therapy with N-CWS and rIL-2 prolonged the MST of the mice more than the therapy with rIL-2 alone. These results suggest that LAK cells potentiated with N-CWS would be useful for immunotherapy of malignant neoplasms.
|
Authors | S Yokota, T Shirasaka, H Nishikawa, S Hosoe, T Ikeda, K Komuta, I Kawase, T Masuno, T Ogura, S Kishimoto |
Journal | Cancer immunology, immunotherapy : CII
(Cancer Immunol Immunother)
Vol. 26
Issue 1
Pg. 11-7
( 1988)
ISSN: 0340-7004 [Print] Germany |
PMID | 3257899
(Publication Type: Journal Article)
|
Chemical References |
- Interleukin-2
- Recombinant Proteins
|
Topics |
- Animals
- Cell Wall
(immunology)
- Interleukin-2
(pharmacology)
- Killer Cells, Natural
(drug effects, immunology)
- Male
- Mice
- Mice, Inbred C57BL
- Nocardia
(immunology)
- Recombinant Proteins
(pharmacology)
|